Genetics Institute Inc. said that two class-action complaintshave been filed against the company in connection with itsproposed merger with American Home Products Corp.

GI, based in Cambridge, Mass., said Lewis J. Bair has filed suitsin Delaware and Massachusetts against the company, each ofits directors and AHP.

The suits allege that GI stockholders will receive inadequateconsideration for their stock in the merger, and seekunspecified monetary damages and injunctive relief, accordingto the company. GI said it will contest the claims.

As a result of the proposed merger, the company this weekdivided the units of its SciGenics Inc. spin-off into separatelytrading components.

Each unit, which had traded under the NASDAQ symbol SCGNZand closed on Monday at $25, has been separated into onecallable share of SciGenics common stock trading under thesymbol SCGN and one warrant for GI stock trading under thesymbol GENIW.

SCGN closed Thursday at $19.50, up $1.50, and GENIW closedunchanged at $8.50.

The units originally were to have separated in January.However, the May 31, 1996, expiration date for the warrantsremains unaffected by the merger, and holders will be able toexercise the warrants for the same consideration as holders ofGI common stock (NASDAQ:GENI) under the merger agreement.GI stock closed unchanged Thursday at $38.50.

(c) 1997 American Health Consultants. All rights reserved.